DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 133 filers reported holding DIPLOMAT PHARMACY INC in Q2 2019. The put-call ratio across all filers is 2.68 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,925,000 | -59.1% | 392,928 | -49.1% | 0.02% | -57.1% |
| Q2 2019 | $4,702,000 | -25.9% | 772,134 | -29.3% | 0.04% | -22.2% |
| Q1 2019 | $6,346,000 | -59.6% | 1,092,180 | -6.3% | 0.04% | -64.6% |
| Q4 2018 | $15,695,000 | -77.1% | 1,166,027 | -67.0% | 0.13% | -71.3% |
| Q3 2018 | $68,619,000 | +39.8% | 3,535,217 | +84.1% | 0.44% | +27.0% |
| Q2 2018 | $49,090,000 | -37.8% | 1,920,572 | -51.0% | 0.35% | -39.5% |
| Q1 2018 | $78,969,000 | +2.9% | 3,919,051 | +2.5% | 0.58% | +2.5% |
| Q4 2017 | $76,751,000 | -8.2% | 3,824,190 | -5.3% | 0.56% | -7.0% |
| Q3 2017 | $83,611,000 | -0.5% | 4,037,213 | -28.9% | 0.60% | -1.8% |
| Q2 2017 | $84,023,000 | -3.4% | 5,677,230 | +4.1% | 0.61% | -4.5% |
| Q1 2017 | $87,015,000 | – | 5,455,461 | – | 0.64% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SENZAR ASSET MANAGEMENT, LLC | 445,200 | $7,101,000 | 1.80% |
| Redmile Group, LLC | 1,254,342 | $20,007,000 | 1.30% |
| Irving Magee Investment Management | 166,505 | $2,656,000 | 1.02% |
| BROADVIEW ADVISORS LLC | 376,050 | $5,998,000 | 0.83% |
| Sivik Global Healthcare LLC | 101,000 | $1,611,000 | 0.75% |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 5,455,461 | $87,015,000 | 0.64% |
| Iguana Healthcare Management, LLC | 75,000 | $1,196,000 | 0.59% |
| RIVERBRIDGE PARTNERS LLC | 1,464,286 | $23,355,000 | 0.47% |
| HERMES INVESTMENT MANAGEMENT LTD | 1,772,777 | $28,276,000 | 0.46% |
| Endurant Capital Management LP | 85,043 | $1,356,000 | 0.44% |